121 related articles for article (PubMed ID: 2333355)
1. Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients.
Tandon R; Mann NA; Eisner WH; Coppard N
Psychiatry Res; 1990 Mar; 31(3):235-41. PubMed ID: 2333355
[TBL] [Abstract][Full Text] [Related]
2. Effect of anticholinergics on positive and negative symptoms in schizophrenia.
Tandon R; DeQuardo JR; Goodson J; Mann NA; Greden JF
Psychopharmacol Bull; 1992; 28(3):297-302. PubMed ID: 1480733
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms.
Tandon R; Shipley JE; Greden JF; Mann NA; Eisner WH; Goodson JA
Schizophr Res; 1991; 4(1):23-30. PubMed ID: 2009253
[TBL] [Abstract][Full Text] [Related]
4. Treatment of schizophrenia with anticholinergic medications.
Tandon R; Dequardo JR
Am J Psychiatry; 1995 May; 152(5):814-5. PubMed ID: 7794374
[No Abstract] [Full Text] [Related]
5. Effects of biperiden and amantadine on memory in medicated chronic schizophrenic patients. A Double-blind cross-over study.
Silver H; Geraisy N
Br J Psychiatry; 1995 Feb; 166(2):241-3. PubMed ID: 7728369
[TBL] [Abstract][Full Text] [Related]
6. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
[TBL] [Abstract][Full Text] [Related]
7. No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
Silver H; Geraisy N
Biol Psychiatry; 1995 Sep; 38(6):413-5. PubMed ID: 8547463
[No Abstract] [Full Text] [Related]
8. The effect of the muscarinic M
Vingerhoets C; Bakker G; van Dijk J; Bloemen OJN; Wang Y; Chan RCK; Booij J; van Amelsvoort TAMJ
Eur Neuropsychopharmacol; 2017 Sep; 27(9):854-864. PubMed ID: 28689687
[TBL] [Abstract][Full Text] [Related]
9. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
Chamorro García L
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
[TBL] [Abstract][Full Text] [Related]
10. Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia.
Ogino S; Miyamoto S; Tenjin T; Kitajima R; Ojima K; Miyake N; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Tatsunami S; Kubota H; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):78-83. PubMed ID: 20828595
[TBL] [Abstract][Full Text] [Related]
11. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
Wada Y; Koshino Y; Yamaguchi N
Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and treatment of negative symptoms.
Villeneuve A
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of acute schizophrenic stupor: the effect of biperiden (author's transl)].
Winter E; Grosse R
Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):383-7. PubMed ID: 504345
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
Himei A; Okamura T
Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
[TBL] [Abstract][Full Text] [Related]
15. The anticholinergic biperiden in depressive disorders.
Kasper S; Moises HW; Beckmann H
Pharmacopsychiatria; 1981 Nov; 14(6):195-8. PubMed ID: 7323139
[TBL] [Abstract][Full Text] [Related]
16. The relationship of symptomatology and medication to electrodermal activity in schizophrenia.
Green MF; Nuechterlein KH; Satz P
Psychophysiology; 1989 Mar; 26(2):148-57. PubMed ID: 2567035
[TBL] [Abstract][Full Text] [Related]
17. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
18. Biperiden and piroheptine do not affect the serum level of zotepine, a new antipsychotic drug.
Otani K; Hirano T; Kondo T; Kaneko S; Fukushima Y; Noda K; Tashiro Y
Br J Psychiatry; 1990 Jul; 157():128-30. PubMed ID: 1975759
[TBL] [Abstract][Full Text] [Related]
19. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
[TBL] [Abstract][Full Text] [Related]
20. Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers.
Veselinović T; Vernaleken I; Janouschek H; Kellermann T; Paulzen M; Cumming P; Gründer G
Psychopharmacology (Berl); 2015 May; 232(9):1607-17. PubMed ID: 25373869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
